Medical Research Council Technology (mrct)
LONDON, February 4 - A major centre created by the Medical Research Council (MRC) and MRC
Technology (MRCT) in order to fast-track the discovery and development of
novel drugs, opens its first call for targets today.
LONDON and GTTINGEN, Germany, January 12 - Reference MRCT: MRCT120110
Georg-August-University Gttingen, University of Regensburg
and MRC Technology (MRCT) have signed exclusive license agreements through
MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH,
for the development of a novel therapy of inflammatory and immune diseases
based on the depletion of inflammatory monocytes.
